Vulvodynia is a chronic pain syndrome that affects the vulvar area and often occurs without an identifiable cause or visible pathology categorized in the ICD-9 group 625—specifically ICD-9 625.7, which is for pain and other disorders of the female genital organs. It refers to pain of the vulva unexplained by vulvar or vaginal infection or skin disease.Source: Wikipedia
Within all the people who go to their doctor with vulvodynia, 76% report having pelvic pain, 74% report having sharp abdominal pain, and 52% report having lower abdominal pain. The symptoms that are highly suggestive of vulvodynia are pelvic pain, lower abdominal pain, vaginal pain, and cramps and spasms, although you may still have vulvodynia without those symptoms.
Patients with vulvodynia often receive urinalysis, hematologic tests, radiographic imaging procedure, complete blood count, pelvis exam, standard pregnancy test, kidney function tests and glucose measurement .
The most commonly prescribed drugs for patients with vulvodynia include norethindrone (loestrin fe), sevoflurane, methylergonovine (methergine), rocuronium, mefenamic acid, mebendazole, ceftriaxone-lidocaine, methylene blue, tromethamine, diphtheria antitoxin, tinidazole, liraglutide (victoza) and corticotropin (acthar) .
|Norethindrone (Loestrin Fe)||$59|
Groups of people at highest risk for vulvodynia include age 30-44 years, sex == female and age 15-29 years. On the other hand, sex == male and age < 1 years almost never get vulvodynia.